DLB
Dolby Laboratories, Inc.
NYSE · Technology · Information Technology Services · US
$61.66
−0.42%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.4B | 1.3B | 1.3B | 1.3B | 1.3B |
| Cost of Revenue | 167.8M | 160.1M | 140.5M | 152.6M | 141.4M |
| Gross Profit | 1.2B | 1.2B | 1.1B | 1.1B | 1.1B |
| Operating Expenses | |||||
| R&D Expense | 265.9M | 261.8M | 263.7M | 271.5M | 261.2M |
| SG&A Expense | 658.8M | 647.2M | 604.9M | 612.8M | 634.0M |
| General & Admin Expense | 295.5M | 286.5M | 270.4M | 258.5M | 275.3M |
| Selling & Marketing Expense | 363.3M | 360.7M | 334.5M | 354.4M | 358.7M |
| Other Expenses | 16.6M | 15.0M | — | — | — |
| Total Operating Expenses | 941.3M | 924.0M | 868.5M | 884.4M | 895.2M |
| Cost and Expenses | 1.1B | 1.1B | 1.0B | 1.0B | 1.0B |
| Operating Income (EBIT) | 245.2M | 265.0M | 264.7M | 262.8M | 217.2M |
| Non-Operating | |||||
| Interest Income | 13.5M | 15.4M | 34.1M | 28.1M | 6.6M |
| Interest Expense | 4.1M | — | — | — | — |
| Net Interest Income | 9.4M | 15.4M | 34.1M | 28.1M | 6.6M |
| Other Non-Op Income/Expense | 31.5M | 38.5M | 47.8M | (12.8M) | (1.9M) |
| Non-Operating Income (excl Interest) | (24.3M) | (15.0M) | (47.8M) | 12.8M | 1.9M |
| EBT (Pre-Tax Income) | 276.8M | 303.5M | 312.5M | 250.1M | 215.3M |
| Income Tax Expense | 48.8M | 47.0M | 48.2M | 48.4M | 31.4M |
| Bottom Line | |||||
| Net Income | 226.2M | 255.0M | 261.8M | 200.7M | 184.1M |
| Earnings from Cont. Ops | 228.0M | 256.5M | 264.3M | 201.6M | 183.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 226.2M | 255.0M | 261.8M | 200.7M | 184.1M |
| Per Share | |||||
| Basic EPS | $2.38 | $2.66 | $2.74 | $2.00 | $1.84 |
| Diluted EPS | $2.35 | $2.62 | $2.69 | $1.96 | $1.81 |
| Revenue Per Share | $14.37 | $14.07 | $13.33 | $13.57 | $12.54 |
| Shares | |||||
| Basic Shares Outstanding | 94.2M | 95.9M | 95.5M | 95.8M | 100.0M |
| Diluted Shares Outstanding | 94.5M | 97.5M | 97.3M | 97.6M | 102.0M |
| Profitability Metrics | |||||
| EBITDA | 372.8M | 378.6M | 399.8M | 345.6M | 318.9M |
| D&A | 103.3M | 98.6M | 87.3M | 95.5M | 103.6M |
| EBIT | 269.5M | 280.0M | 312.5M | 250.1M | 215.3M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026